# OneBlood, Inc. – FDA Inspection, Mar 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/abd896a3-a5e7-41f0-9808-a26c20e95026
Source feed: FDA_Inspections

> FDA inspection 1200346 of OneBlood, Inc., March 21, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 606. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200346
- Company Name: OneBlood, Inc.
- Inspection Date: 2023-03-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1304338 - 2026-01-26](https://www.keypedia.com/records/fda_inspections/oneblood-inc/6e05d5ea-152b-47b1-97fd-e6ebbdb88433)
- FDA Inspection 1080683 - 2019-02-21
- FDA Inspection 1012283 - 2017-02-02
- FDA Inspection 905875 - 2014-12-03
- FDA Inspection 817493 - 2013-01-30

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/charles-d-boison/b128f4a3-c1b1-409f-9291-27deb111d1e5)

Company: https://www.keypedia.com/companies/oneblood-inc/4ad69618-4cb7-4db0-be9a-d6ec5d8eafb9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
